BSEM

Zacks Small Cap Research – BSEM: Medicare Issues Shouldn’t Impact BioStem – Go Health Pro

by

By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT We don’t often write about short-term movements in stocks we cover but the move in BioStem Technologies, Inc. (OTC:BSEM) has coincided with what seems to have been perceived as a fundamental change in the company and we want to make sure investors know the … Read more

Zacks Small Cap Research – BSEM Announces Expanding Market and Stellar Test Results – Go Health Pro

by

By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company states its mission is “to discover, develop and produce the most effective regenerative medicine … Read more

x